Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Clinical nutrition

Liver steatosis in adult patients on home parenteral nutrition

Abstract

Background

In patients with chronic intestinal failure (CIF) and long-term home parenteral nutrition (HPN), liver steatosis is a known late complication, which can progress to intestinal failure-associated liver disease (IFALD). Magnetic resonance imaging (MRI) provides a qualitative and quantitative assessment of liver steatosis. The aim of our study was to assess the prevalence of liver steatosis and find possible new factors that could be connected to liver steatosis in CIF patients on HPN therapy.

Methods

Patients diagnosed with CIF and undergoing long-term HPN therapy were enrolled in a prospective cohort study. Clinical, laboratory and body composition data were collected from their medical records between January 2017 and November 2018. Liver steatosis was diagnosed using 3 Tesla Siemens MRI scanner. The associations between various risk factors and liver steatosis were calculated using uni- and multivariate logistic regression.

Results

In our study, we included 63 adult patients with CIF on HPN therapy. The median HPN therapy duration was 70 weeks (IQR 22–203). The prevalence of liver steatosis was 28.6%. Serum cholesterol level, CRP and FFMI were statistically significantly associated with liver steatosis.

Conclusion

The results of our study indicate that CIF patients on HPN therapy experience a low risk of liver disease if they adhere to a well-controlled treatment regime. We found that MRI is an appropriate diagnostic tool for monitoring liver steatosis in patients on long-term PN. With respect to already known risk factors for liver steatosis, we did find a newly described association between FFMI and liver steatosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. EASL–EASD–EASO. Clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402. http://linkinghub.elsevier.com/retrieve/pii/S0168827815007345.

  2. Lee SS, Park SH, Kim HJ, Kim SY, Kim M-Y, Kim DY, et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol. 2010;52:579–85. http://www.ncbi.nlm.nih.gov/pubmed/20185194.

    Article  CAS  Google Scholar 

  3. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–50. http://www.ncbi.nlm.nih.gov/pubmed/12198701.

    Article  Google Scholar 

  4. Raptis DA, Fischer MA, Graf R, Nanz D, Weber A, Moritz W, et al. MRI: the new reference standard in quantifying hepatic steatosis? Gut. 2012;61:117–27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21997548.

    Article  Google Scholar 

  5. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51:433–45. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0168827809003900.

    Article  Google Scholar 

  6. Fishbein MH, Stevens WR. Rapid MRI using a modified Dixon technique: a non-invasive and effective method for detection and monitoring of fatty metamorphosis of the liver. Pediatr Radiol. 200131:806–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11692239.

    Article  CAS  Google Scholar 

  7. Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20:7392. http://www.ncbi.nlm.nih.gov/pubmed/24966609.

    Article  Google Scholar 

  8. Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Bekker Jeppesen P, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35:247–307. http://www.espen.org/files/ESPEN-Guidelines/1__ESPEN_guidelines_on_chronic_intestinal_failure_in_adults.pdf.

  9. Pironi L, Goulet O, Buchman A, Messing B, Gabe S, Candusso M, et al. Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN. Clin Nutr. 2012;31:831–45. http://www.ncbi.nlm.nih.gov/pubmed/22658443.

    Article  Google Scholar 

  10. Lal S, Pironi L, Wanten G, Arends J, Bozzetti F, Cuerda C, et al. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: a position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN. Clin Nutr. 2018. http://www.ncbi.nlm.nih.gov/pubmed/30017241.

  11. Abu-Wasel B, Molinari M. Liver disease secondary to intestinal failure. Biomed Res Int. 2014;2014:968357. http://www.ncbi.nlm.nih.gov/pubmed/24551858.

    Article  Google Scholar 

  12. Sasdelli AS, Agostini F, Pazzeschi C, Guidetti M, Lal S, Pironi L. Assessment of intestinal failure associated liver disease according to different diagnostic criteria. Clin Nutr. 2018; https://www.sciencedirect.com/science/article/pii/S0261561418301705.

  13. Dibb M, Teubner A, Theis V, Shaffer J, Lal S. Review article: the management of long-term parenteral nutrition. Aliment Pharm Ther. 2013;37:587–603. http://doi.wiley.com/10.1111/apt.12209.

    Article  CAS  Google Scholar 

  14. Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatol. 2006;43:9–19. http://doi.wiley.com/10.1002/hep.20997.

    Article  Google Scholar 

  15. Florence Lacaille GGVCLDCHIHSKJPRS. Intestinal Failure–associated liver disease: a position paper of the espghan working group of intestinal failure and intestinal transplantation. J Pediatr Gastroenterol Nutr. 2015;60:272–83. https://insights.ovid.com/crossref?an=00005176-201502000-00026.

    Article  CAS  Google Scholar 

  16. Kelly DA. Intestinal failure–associated liver disease: what do we know today? Gastroenterology. 2006;130:S70–7. http://www.ncbi.nlm.nih.gov/pubmed/16473076.

    Article  CAS  Google Scholar 

  17. Pironi L, Joly F, Forbes A, Colomb V, Lyszkowska M, Baxter J, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. 2011;60:17–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21068130.

  18. Couinaud C. Le foie: etudes anatomiques et chirurgicales. Paris: Mason 1957: 400–9 Goldsmith NA, Woodburne RT. The surgical anatomy pertaining to liver resection. Surg Gynecol Obs. 1957;105:310–18.

    Google Scholar 

  19. Ma X, Holalkere N-S, R AK, Mino-Kenudson M, Hahn PF, Sahani D V. Imaging-based quantification of hepatic fat: methods and clinical applications. RadioGraphics. 2009;29:1253–77. http://www.ncbi.nlm.nih.gov/pubmed/19755595.

    Article  Google Scholar 

  20. Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, et al. Accuracy of MR Imaging–estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology. 2015;274:416–25. http://www.ncbi.nlm.nih.gov/pubmed/25247408.

    Article  Google Scholar 

  21. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011;21:87–97. http://www.ncbi.nlm.nih.gov/pubmed/20680289.

    Article  Google Scholar 

  22. Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150:626–.e7. http://www.ncbi.nlm.nih.gov/pubmed/26677985.

    Article  Google Scholar 

  23. Lee DH. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clin Mol Hepatol. 2017. http://www.ncbi.nlm.nih.gov/pubmed/28994271.

  24. van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, ten Kate FJ, van Gulik TM, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1 H MR spectroscopy. Radiology. 2010;256:159–68. http://www.ncbi.nlm.nih.gov/pubmed/20574093.

    Article  Google Scholar 

  25. Buchman A, Naini B, Spilker B. The differentiation of intestinal-failure-associated liver disease from nonalcoholic fatty liver and nonalcoholic steatohepatitis. Semin Liver Dis. 2017;37:033–44. http://www.thieme-connect.de/DOI/DOI?10.1055/s-0036-1597771.

    Article  Google Scholar 

  26. Kudsk KA, Munoz-Del-Rio A, Busch RA, Kight CE, Schoeller DA. Stratification of fat-free mass index percentiles for body composition based on National Health and Nutrition Examination Survey III Bioelectric Impedance Data. JPEN J Parenter Enteral Nutr. 2017;41:249–57. http://www.ncbi.nlm.nih.gov/pubmed/26092851.

    Article  Google Scholar 

  27. Dulloo AG, Jacquet J, Solinas G, Montani J-P, Schutz Y. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes. 2010;34(S2):S4–17. http://www.nature.com/articles/ijo2010234.

    Article  Google Scholar 

  28. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132:525–32. http://www.ncbi.nlm.nih.gov/pubmed/10744588.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study would not be possible without the help from our nursing staff. Special thanks goes to Laura Petrica and Nizra Palamar.

Author information

Authors and Affiliations

Authors

Contributions

TJ, PP and NRK. TJ contributed to the data collection, analyzed the data and drafted the manuscript. PP contributed to conception of the study, data interpretation and reviewed/edited the paper. NRK was responsible for the concept/ design of the study, and contributed to the data analysis and interpretation, and revised the paper. All authors read and approved the final paper and agree to be accountable for all aspects of work ensuring integrity and accuracy.

Corresponding author

Correspondence to Taja Jordan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jordan, T., Popovič, P. & Rotovnik Kozjek, N. Liver steatosis in adult patients on home parenteral nutrition. Eur J Clin Nutr 74, 255–260 (2020). https://doi.org/10.1038/s41430-019-0455-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41430-019-0455-4

This article is cited by

Search

Quick links